Year 8, Number 31, January 2006

 

Oncología II
Article N°AJ31-19

 

 


Colmenter, LF; Celedón, P.; Salazar, C.; Díaz, S.

Centro Diagnóstico Docente Las Mercedes. Caracas, Venezuela. e-Mail medicinanuclear@cddlasmercedes.com

Cita/Reference:
Colmenter, LF; Celedón, P.; Salazar, C.; Díaz, S. Clinical Experience in Oncologic Patients with the First CT/PET Scanner in Venezuela. Alasbimn Journal 8(31): January 2006.



Clinical Experience in Oncologic Patients with the First CT/PET Scanner in Venezuela


Objectives: CT-PET is a combination of anatomic and metabolic information provided by two different technologies. These aspects are fundamental in the evaluation and follow up of malignancies. Despite the economical situation of our country, we received the support from Simón Bolívar University (USB), Central University of Venezuela (UCV), the Ministry of Energy and the Ministry of Health in order to achieve the development of CT/PET in Venezuela. The objective of this study is to share our experience with CT/PET in oncologic patients.

Methods: We reported one thousand (1000) cases of patients who underwent CT/PET with FDG over a period of two years in our center, the most common studied malignancies, their indications, and diagnostics.

Results: The average age was 56 years (range 1-91). Sixty two percent of the patients were masculine. The more frequent malignancies were hematopoietic (16%), lung (11%), prostate (9%), breast (8%), and colon (7%). The indications were screening of a tumor in healthy patients (30%), differential diagnosis (20%), staging (19%), and restaging (15%). Sixty five percent of the studies were reported as positive for cancer.

Conclusions: Is necessary to increase our experience in CT/PET but so far our data is similar to many centers all over the world.

 


2-Deoxy-2-Fluoro-D-glucosa marcada con F-18 (PET/RM) en la determinación de recidivas tumorales vs. perfusión por resonancia magnética en pacientes con tumoraciones del sistema nervioso central | Comparación de PET-TC versus TC para detectar enfermedad residual post-tratamiento en pacientes con linfoma. Nuestra experiencia | Utilidad del PET-FDG en tumores gastrointestinales | Implementación de un banco de datos integrado por información general e imágenes morfo-metabólicas con características de variantes normales | Niveles de Cyfra 21.1 en pacientes con Nódulo Pulmonar Solitario y Cáncer Pulmonar evaluados mediante PET-CT | CT/PET en Cancer de Mama: Experiencia en Venezuela | Clinical Experience in Oncologic Patients with the First CT/PET Scanner in Venezuela | Evaluación de ganglios regionales en pacientes con carcinoma de pene mediante dos técnicas nucleares: resultados preliminares | Tratamiento de 351 pacientes con cáncer de mama, ganglio centinela negativo, sin disección axilar posterior | Sentinel Lymph Node in Breast Cancer – Preliminary Experience | Patrones Linfoscintigráficos del Drenaje Linfático de la Pared Torácica Posterior a Mastectomía Radical Modificada Tipo Madden y Disección Axilar Homolateral en Pacientes con Cáncer De Mama | Cancer mamario (CM): investigación del ganglio centinela (GC). Estudio prospectivo sin linfadectomia axilar (LA) posterior | Estudio del ganglio centinela con sonda radioguiada, primeras experiencias en el Ecuador | Avaliação retrospectiva da Pesquisa do Linfonodo Sentinela (PLS) em 92 pacientes com neoplasia maligna mamária | Print

 

 

Sitio desarrollado por SISIB - Universidad de Chile